Drug Approval | November 22, 2023
Truqap plus Faslodex approved in the US for patients with advanced HR-positive breast cancer
First-in-class AKT inhibitor has potential to reshape treatment for breast cancer patients
First-in-class AKT inhibitor has potential to reshape treatment for breast cancer patients
Narayana Hrudayalaya has reported total income of Rs. 1323.64 crores during the period ended September 30, 2023
Yesafili, received marketing authorization approval from the European Commission for the European Union
Revenue in the three months ended on Oct. 1 also slipped by 42% to US$ 13.23 billion
Merck to pay Daiichi Sankyo a $4 billion upfront payment in addition to $1.5 billion in continuation payments over the next 24 months
Pant delivers keynote address at National Conclave on “Augmented Zoonotic Diseases Surveillance at Human – Wildlife Interface”
Prateek has more than 23 years of rich experience in Human Resource
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
Apollo Telehealth has established more than 700 centers, in 7 states
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
Subscribe To Our Newsletter & Stay Updated
